I-131 tositumomab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for I-131 tositumomab, covering 2007-09-17 to 2018-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]